rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2003-2-5
|
pubmed:abstractText |
Pulmonary aspergillosis and other invasive fungal infections (IFIs) commonly complicate the management of patients with acute leukemia. Standard amphotericin-based therapies may be ineffective for many patients and the available salvage agents (itraconazole and caspofungin) are reported to possess only moderate activity against resistant infections. Laboratory evidence suggests a synergistic interaction between amphotericin and caspofungin. The authors treated a group of patients with amphotericin-refractory IFIs with the combination of caspofungin and amphotericin (or liposomal amphotericin).
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1025-32
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12569602-Acute Disease,
pubmed-meshheading:12569602-Adult,
pubmed-meshheading:12569602-Aged,
pubmed-meshheading:12569602-Amphotericin B,
pubmed-meshheading:12569602-Anti-Bacterial Agents,
pubmed-meshheading:12569602-Aspergillosis,
pubmed-meshheading:12569602-Drug Therapy, Combination,
pubmed-meshheading:12569602-Echinocandins,
pubmed-meshheading:12569602-Female,
pubmed-meshheading:12569602-Humans,
pubmed-meshheading:12569602-Leukemia,
pubmed-meshheading:12569602-Lung Diseases, Fungal,
pubmed-meshheading:12569602-Male,
pubmed-meshheading:12569602-Middle Aged,
pubmed-meshheading:12569602-Peptides,
pubmed-meshheading:12569602-Peptides, Cyclic,
pubmed-meshheading:12569602-Pneumonia,
pubmed-meshheading:12569602-Retrospective Studies
|
pubmed:year |
2003
|
pubmed:articleTitle |
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
|
pubmed:affiliation |
Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|